Assessing Safety and Performance of the Novel CytaCoat Foley Catheter
Recruiting now · Not applicable
Conditions studied: Safety of the CytaCoat Foley Catheter, Performance of the CytaCoat Foley Catheter
In brief
This study is a prospective, single-center, single-blind, randomized, parallel assignment, controlled study to evaluate the safety and performance of the novel CytaCoat Foley catheter when compared to a Sterimed uncoated Foley catheter. Participants will include male and female adult subjects who require an indwelling urinary catheter for an expected duration of minimum 72 hours to 14 days. The primary purpose of the clinical investigation is to determine whether the novel CytaCoat Foley catheter is safe to use in subjects. Safety is assessed by evaluation of adverse events (according to ISO 14155:2020). The secondary objective is to assess the overall performance of the CytaCoat Foley catheter by evaluating usability experience by the healthcare personnel and subjects measured by using NRS (Numeric Rating Scale) scale. Furthermore, the exploratory objective of this study is to assess for the presence of bacteriuria in urine and fouling / biofilm analysis of the used catheters.
Key facts
- Study ID
- NCT07070921
- Run by
- CytaCoat AB
- People needed
- 30
- Starts
- 2025-06-02
- Expected to finish
- 2025-09-01
- Last updated by the study team
- 2025-07-17
Who can join
Age: 18 and older, up to 84. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Adults, male and female, aged 18 to 84 years
- Subjects in need of a urinary catheter for a minimum of 72 hours
- Subjects who can accommodate a size of 14, 16 and 18 French Foley catheter
- Written informed consent
- Subject to be conscious
You may not qualify if…
- Pregnant or breastfeeding women
- Critically ill subjects with a life-threatening disorder (Subjects having an APACHE II score ≥ 28)
- Subject with a known silicone allergy or sensitivity
- Previous enrolment in the present study
- Simultaneous participation in another clinical study that may impact the primary endpoint
- Subject with pre-existing urinary catheter for more than 48 hours
- Subject with symptomatic genitourinary pathology
- Expected severe non-compliance to the protocol as judged by the principal investigator
Where it is running
- St. John's Medical College Hospital — Bangalore, Karnataka, India (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.